Corbus is a biotechnology company that develops and commercializes novel therapeutics for the treatments of inflammatory and fibrotic diseases.Read more
$ < 1M
Corbus Pharmaceuticals's revenue is the ranked 29th among it's top 10 competitors. The top 10 competitors average 932.7M. Over the last two quarters, Corbus Pharmaceuticals's revenue has decreased by 28.7%. Specifically, in Q3 2021's revenue was $ < 1M; in Q2 2021, it was $ < 1M.